UB Paderborn / Katalog / Suche / in CDI

Fragment-Based Discovery of Type I Inhibitors of Maternal Embryonic Leucine Zipper Kinase

ACS medicinal chemistry letters, 2015-01, Vol.6 (1), p.25-30

2015

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase

ACS medicinal chemistry letters, 2015-01, Vol.6 (1), p.31-36

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of R146225 as a novel, orally active inhibitor of interleukin-5 biosynthesis

The Journal of pharmacology and experimental therapeutics, 2000-11, Vol.295 (2), p.655

2000

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of LIAZAL, a retinoic acid metabolism blocking agent (RAMBA) with potential clinical applications in oncology and dermatology

Bioorganic & medicinal chemistry letters, 1998-02, Vol.8 (3), p.267-272

1998

Link zum Volltext

Verfügbarkeit prüfen

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro

Thrombosis and haemostasis, 1989, Vol.61 (1), p.35

1989

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds

The Journal of pharmacology and experimental therapeutics, 1992-10, Vol.263 (1), p.6

1992

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1361: Fragment based drug discovery of selective inhibitors of Fibroblast Growth Factor Receptor (FGFR)

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1361-1361

2011

Link zum Volltext

Verfügbarkeit prüfen

R 75251, a new inhibitor of steroid biosynthesis

The Prostate, 1990, Vol.16 (4), p.345-357

1990

Link zum Volltext

Verfügbarkeit prüfen

R 76713, a new specific non-steroidal aromatase inhibitor

Journal of steroid biochemistry, 1989-06, Vol.32 (6), p.781-788

1989

Link zum Volltext

Verfügbarkeit prüfen

5-Imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors

Bioorganic & medicinal chemistry letters, 2003-05, Vol.13 (9), p.1543-1547

2003

Link zum Volltext

Verfügbarkeit prüfen

Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors

European journal of medicinal chemistry, 2005-06, Vol.40 (6), p.597-606

2005

Link zum Volltext

Verfügbarkeit prüfen

Substituted azoloquinolines and -quinazolines as new potent Farnesyl Protein Transferase inhibitors

Bioorganic & medicinal chemistry letters, 2003-12, Vol.13 (24), p.4365-4369

2003

Link zum Volltext

Verfügbarkeit prüfen

4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the farnesyltransferase inhibitor ZARNESTRA

Bioorganic & medicinal chemistry letters, 2003-12, Vol.13 (24), p.4361-4364

2003

Link zum Volltext

Verfügbarkeit prüfen

The synthesis of 5-carboxamido-4-hydroxy-3-(β-D-ribofuranosyl)-thiophene derivatives, analogues of pyrazofurin

Tetrahedron, 1984, Vol.40 (13), p.2479-2485

1984

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Evaluation of 1,2,4-Triazinylphenylalkylthiazolecarboxylic Acid Esters as Cytokine-Inhibiting Antedrugs with Strong Bronchodilating Effects in an Animal Model of Asthma

Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.2167-2175

2005

Link zum Volltext

Verfügbarkeit prüfen

588 POSTER JNJ-26483327 is a novel multi-targeted tyrosine kinase inhibitor with cellular activity against EGFR, Her2, Src and VEGFR3

European journal of cancer supplements, 2006-11, Vol.4 (12), p.178-178

2006

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors

Bioorganic & medicinal chemistry letters, 2002-02, Vol.12 (4), p.653-658

2002

Link zum Volltext

Verfügbarkeit prüfen

587 POSTER Efficacy of the novel multi-targeted kinase inhibitor JNJ-26483327 in experimental brain and bone metastases models

European journal of cancer supplements, 2006-11, Vol.4 (12), p.178-178

2006

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of LIAZALTM, a retinoic acid metabolism blocking agent (ramba) with potential clinical applications in oncology and dermatology

Bioorganic & medicinal chemistry letters, 1998-02, Vol.8 (3), p.267-272

1998

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of LIAZAL TM, a retinoic acid metabolism blocking agent (ramba) with potential clinical applications in oncology and dermatology

Bioorganic & medicinal chemistry letters, 1998, Vol.8 (3), p.267-272

1998

Link zum Volltext

Verfügbarkeit prüfen

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule

Progress in clinical and biological research, 1989, Vol.301, p.567

1989

Link zum Volltext

Verfügbarkeit prüfen

Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo

Journal of steroid biochemistry and molecular biology, 1990-12, Vol.37 (6), p.1049-1054

1990

Link zum Volltext

Verfügbarkeit prüfen

Chemical ionization desorption mass spectrometry as an additional tool for the structure elucidation of nucleosides

Biological Mass Spectrometry, 1980-09, Vol.7 (9), p.377-380

1980

Link zum Volltext

Verfügbarkeit prüfen

ChemInform Abstract: Synthesis of Liazal10s, a Retinoic Acid Metabolism Blocking Agent (RAMBA) with Potential Clinical Applications in Oncology and Dermatology

ChemInform, 1998-06, Vol.29 (25), p.no-no

1998

Link zum Volltext

Verfügbarkeit prüfen

Multiple Regression Model for Load Rating of Reinforced Concrete Bridges

Transportation research record, 2020-07, Vol.2674 (7), p.361-372

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Fragment-Based Discovery of Type I Inhibitors of Maternal Embryonic Leucine Zipper Kinase

Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase

Identification of R146225 as a novel, orally active inhibitor of interleukin-5 biosynthesis

Synthesis of LIAZAL, a retinoic acid metabolism blocking agent (RAMBA) with potential clinical applications in oncology and dermatology

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro

Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds

Abstract 1361: Fragment based drug discovery of selective inhibitors of Fibroblast Growth Factor Receptor (FGFR)

R 75251, a new inhibitor of steroid biosynthesis

R 76713, a new specific non-steroidal aromatase inhibitor

5-Imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors

Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors

Substituted azoloquinolines and -quinazolines as new potent Farnesyl Protein Transferase inhibitors

4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the farnesyltransferase inhibitor ZARNESTRA

The synthesis of 5-carboxamido-4-hydroxy-3-(β-D-ribofuranosyl)-thiophene derivatives, analogues of pyrazofurin

Synthesis and Biological Evaluation of 1,2,4-Triazinylphenylalkylthiazolecarboxylic Acid Esters as Cytokine-Inhibiting Antedrugs with Strong Bronchodilating Effects in an Animal Model of Asthma

588 POSTER JNJ-26483327 is a novel multi-targeted tyrosine kinase inhibitor with cellular activity against EGFR, Her2, Src and VEGFR3

Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors

587 POSTER Efficacy of the novel multi-targeted kinase inhibitor JNJ-26483327 in experimental brain and bone metastases models

Synthesis of LIAZALTM, a retinoic acid metabolism blocking agent (ramba) with potential clinical applications in oncology and dermatology

Synthesis of LIAZAL TM, a retinoic acid metabolism blocking agent (ramba) with potential clinical applications in oncology and dermatology

R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule

Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo

Chemical ionization desorption mass spectrometry as an additional tool for the structure elucidation of nucleosides

ChemInform Abstract: Synthesis of Liazal10s, a Retinoic Acid Metabolism Blocking Agent (RAMBA) with Potential Clinical Applications in Oncology and Dermatology

Multiple Regression Model for Load Rating of Reinforced Concrete Bridges

Suchergebnisse filtern